SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Gut microbiota development during infancy: Impact of introducing allergenic foods

Marrs, T; Jo, J-H; Perkin, MR; Rivett, DW; Witney, AA; Bruce, KD; Logan, K; Craven, J; Radulovic, S; Versteeg, SA; et al. Marrs, T; Jo, J-H; Perkin, MR; Rivett, DW; Witney, AA; Bruce, KD; Logan, K; Craven, J; Radulovic, S; Versteeg, SA; van Ree, R; McLean, WHI; Strachan, DP; Lack, G; Kong, HH; Flohr, C (2021) Gut microbiota development during infancy: Impact of introducing allergenic foods. Journal of Allergy and Clinical Immunology, 147 (2). 613-621.e9. ISSN 0091-6749 https://doi.org/10.1016/j.jaci.2020.09.042
SGUL Authors: Perkin, Michael Richard

[img] Microsoft Word (.docx) Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (84kB)
[img]
Preview
PDF (Online materials) Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (1MB) | Preview

Abstract

Background The gut microbiota potentially plays an important role in the immunologic education of the host during early infancy. Objective We sought to determine how the infant gut microbiota evolve during infancy, particularly in relation to hygiene-related environmental factors, atopic disorders, and a randomized introduction of allergenic solids. Methods A total of 1303 exclusively breast-fed infants were enrolled in a dietary randomized controlled trial (Enquiring About Tolerance study) from 3 months of age. In this nested longitudinal study, fecal samples were collected at baseline, with additional sampling of selected cases and controls at 6 and 12 months to study the evolution of their gut microbiota, using 16S ribosomal RNA gene-targeted amplicon sequencing. Results In the 288 baseline samples from exclusively breast-fed infant at 3 months, the gut microbiota was highly heterogeneous, forming 3 distinct clusters: Bifidobacterium-rich, Bacteroides-rich, and Escherichia/Shigella-rich. Mode of delivery was the major discriminating factor. Increased Clostridium sensu stricto relative abundance at 3 months was associated with presence of atopic dermatitis on examination at age 3 and 12 months. From the selected cases and controls with longitudinal samples (n = 70), transition to Bacteroides-rich communities and influx of adult-specific microbes were observed during the first year of life. The introduction of allergenic solids promoted a significant increase in Shannon diversity and representation of specific microbes, such as genera belonging to Prevotellaceae and Proteobacteria (eg, Escherichia/Shigella), as compared with infants recommended to exclusively breast-feed. Conclusions Specific gut microbiota characteristics of samples from 3-month-old breast-fed infants were associated with cesarean birth, and greater Clostridium sensu stricto abundance was associated with atopic dermatitis. The randomized introduction of allergenic solids from age 3 months alongside breast-feeding was associated with differential dynamics of maturation of the gut microbial communities.

Item Type: Article
Additional Information: © 2020. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
Keywords: Allergy, 1107 Immunology
SGUL Research Institute / Research Centre: Academic Structure > Population Health Research Institute (INPH)
Journal or Publication Title: Journal of Allergy and Clinical Immunology
ISSN: 0091-6749
Dates:
DateEvent
4 February 2021Published
18 September 2020Accepted
Publisher License: Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0
Projects:
Project IDFunderFunder ID
T07051Food Standards Agencyhttp://dx.doi.org/10.13039/501100000354
MC_G1001205Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
NIHRCS/01/2008/009National Institute for Health Researchhttp://dx.doi.org/10.13039/501100000272
5047iBritish Skin Foundationhttp://dx.doi.org/10.13039/501100000296
092530/Z/10/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
090066/B/09/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
098439/Z/12/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
HI15C1095Korean Health Technology R&D ProjectUNSPECIFIED
821511Medicines Initiative 2 Joint UndertakingUNSPECIFIED
URI: https://openaccess.sgul.ac.uk/id/eprint/112411
Publisher's version: https://doi.org/10.1016/j.jaci.2020.09.042

Actions (login required)

Edit Item Edit Item